Brief: Dermapharm Holding Confirms Outlook For 2024
Aug 14 (Reuters) - Dermapharm Holding SE DMPG.DE :
* EQS-NEWS: SUSTAINED ORGANIC GROWTH IN HIGH-MARGIN EXISTING
BRANDED PHARMACEUTICAL BUSINESS
* DERMAPHARM HOLDING SE - CONFIRMS OUTLOOK FOR 2024 OVERAL
Source text for Eikon: ID:nEQ95lfDya
Further company coverage: DMPG.DE
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
Recent news on Dermapharm Holding SE
See all newsBrief: Dermapharm Confirms 2026 Forecast
Corrected: Germany's Dermapharm prelim H1 revenue rises, maintains outlook
Brief: Dermapharm Holding - Confirms Full-Year Guidance For 2026
Brief: Dermapharm Spokesperson - Dermapharm Is Engaged In A Constructive Dialogue With The Regulator
Refile: BUZZ-Dermapharm Holding slips after BaFin's audit